NCT01556113View on ClinicalTrials.gov

Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Non Alcoholic Fatty Liver DiseaseSteatohepatitisHypertriglyceridemiaAlanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Interventions
OTHER

Omega diet

Eligible subjects will receive omega rich diet for 12 weeks with weekly appointments to obtain food records, draw serum samples and provide meals.

Trial Locations (1)

06510

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Yale University

OTHER

NCT01556113 - Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease | Biotech Hunter | Biotech Hunter